Timothy Maloney - Articles and news items

Novartis logo

Novartis drug Galvus® approved in EU for monotherapy use in patients with type 2 diabetes unable to take metformin

Industry news, News / 6 February 2012 / Chamberlain Healthcare PR

The European Commission has approved the use of Galvus® (vildagliptin)…

Novartis logo

Novartis drug Galvus® approved in EU

Industry news, News / 5 December 2011 / Novartis

The European Commission has approved Galvus® (vildagliptin) (50 mg once a day) for the treatment of type 2 diabetes patients with moderate or severe renal impairment…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+